Phase I/II study of the antibody-drug conjugate glembatumumab vedotin in patients with locally advanced or metastatic breast cancer. (Q50448767)
Jump to navigation
Jump to search
scientific article published on 29 September 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I/II study of the antibody-drug conjugate glembatumumab vedotin in patients with locally advanced or metastatic breast cancer. |
scientific article published on 29 September 2014 |
Statements
Phase I/II study of the antibody-drug conjugate glembatumumab vedotin in patients with locally advanced or metastatic breast cancer (English)
Johanna Bendell
Mansoor Saleh
Peter M Siegel
Lowell Hart
Surendra Sirpal
Suzanne Jones
Jennifer Green
Elizabeth Crowley
Tibor Keler
Thomas Davis
29 September 2014